182 related articles for article (PubMed ID: 35867945)
1. Presentation of concurrent thrombotic thrombocytopenic purpura and Graves' disease.
Casasanta NA; Shah N; Troy K; Edwards C; Patel RB
Blood Coagul Fibrinolysis; 2022 Oct; 33(7):422-424. PubMed ID: 35867945
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic thrombocytopenic purpura precipitated by thyrotoxicosis.
Chhabra S; Tenorio G
J Clin Apher; 2012 Nov; 27(5):265-6. PubMed ID: 22644892
[TBL] [Abstract][Full Text] [Related]
3. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic thrombocytopenic purpura and Graves disease.
Chaar BT; Kudva GC; Olsen TJ; Silverberg AB; Grossman BJ
Am J Med Sci; 2007 Aug; 334(2):133-5. PubMed ID: 17700205
[TBL] [Abstract][Full Text] [Related]
5. [Frontline clinical practice for thrombotic thrombocytopenic purpura].
Miyakawa Y
Rinsho Ketsueki; 2020; 61(9):1331-1337. PubMed ID: 33162533
[TBL] [Abstract][Full Text] [Related]
6. [Thrombotic thrombocytopenic purpura].
Yoshitaka M
Rinsho Ketsueki; 2021; 62(5):430-434. PubMed ID: 34108326
[TBL] [Abstract][Full Text] [Related]
7. Interferon-α is not elevated in idiopathic thrombotic thrombocytopenic purpura patients.
Watanaboonyongcharoen P; Whinna HC; Park YA
J Clin Apher; 2014 Dec; 29(6):336-8. PubMed ID: 24764259
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
9. Stroke in thrombotic thrombocytopenic purpura induced by thyrotoxicosis: a case report.
Bellante F; Redondo Saez P; Springael C; Dethy S
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1744-6. PubMed ID: 24674955
[TBL] [Abstract][Full Text] [Related]
10. Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.
Kalish Y; Rottenstreich A; Rund D; Hochberg-Klein S
J Thromb Thrombolysis; 2016 Aug; 42(2):155-60. PubMed ID: 26867546
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A
Iio R; Akiyama S; Mitsumoto K; Iwata Y; Okushima H; Shimada K; Ota N; Tomida K; Fushimi H; Shoji T; Matsumoto M; Hayashi T
BMC Nephrol; 2020 Oct; 21(1):431. PubMed ID: 33046023
[TBL] [Abstract][Full Text] [Related]
12. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
Mariotte E; Azoulay E; Galicier L; Rondeau E; Zouiti F; Boisseau P; Poullin P; de Maistre E; Provôt F; Delmas Y; Perez P; Benhamou Y; Stepanian A; Coppo P; Veyradier A;
Lancet Haematol; 2016 May; 3(5):e237-45. PubMed ID: 27132698
[TBL] [Abstract][Full Text] [Related]
14. Alemtuzumab-induced immune-mediated thrombotic thrombocytopenic purpura: A newly described drug-related autoimmune disease.
Bourdin V; Fossé Q; Lambotte O; Joly B; Coppo P; Anguel N; Labeyrie C
Br J Haematol; 2024 Apr; 204(4):1459-1463. PubMed ID: 38112161
[TBL] [Abstract][Full Text] [Related]
15. Current insight into thrombotic thrombocytopenic purpura.
Verbeke L; Delforge M; Dierickx D
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
17. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
Martin SD; McGinnis E; Smith TW
Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies: Lessons learned from a 14-year retrospective study.
Tau J; Fernando LP; Munoz MC; Poh C; Krishnan VV; Dwyre DM
Ther Apher Dial; 2023 Feb; 27(1):136-145. PubMed ID: 35501999
[TBL] [Abstract][Full Text] [Related]
19. Recognizing and managing hereditary and acquired thrombotic thrombocytopenic purpura in infants and children.
Siddiqui A; Journeycake JM; Borogovac A; George JN
Pediatr Blood Cancer; 2021 May; 68(5):e28949. PubMed ID: 33660913
[TBL] [Abstract][Full Text] [Related]
20. Graves disease-induced thrombotic thrombocytopenic purpura: a case report.
Chaughtai S; Khan I; Gupta V; Chaughtai Z; Ong R; Asif A; Hossain MA
J Med Case Rep; 2019 Dec; 13(1):377. PubMed ID: 31831041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
